CentralCharts: Supercharge your portfolio with groundbreaking tools.

FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Name of exempt principal trader: Investec Bank plc (b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree abrdn European Logistics Income plc (c) Name of the party to the offer with which exempt principal...

JP Jenkins Ltd e-therapeutics plc shares now trading on JP Jenkins 09-May-2024 / 07:30 GMT/BST The issuer is solely responsible for the content of this announcement. 9th May 2024 JPJ: ETX ISIN: GB00B2823H99 e-therapeutics plc ("e-therapeutics" or "ETX" or the "Company") Shares now trading on JP Jenkins London, UK, 9th May 2024 – e-therapeutics plc (AIM: ETX), a company integrating computational power and biological data to discover life-transforming RNAi medicines, today announces its shares...

London & Associated Properties Plc - Annual Report and Notice of AGM PR Newswire LONDON, United Kingdom, May 09 FOR IMMEDIATE RELEASE 9 May 2024 London & Associated Properties PLC Annual Report and Notice of AGM This is to confirm that London & Associated Properties PLC ("LAP" or "the Company") has posted its Annual Report and Accounts for the year ended 31 December 2023 and Notice of Annual General Meeting (to be held on Wednesday, 26 June 2024 ). The document is now available on the Company's...

Tokyo, Japan and Cambridge, UK, 9 May 2024 – Nxera Pharma (“the Company” or “Nxera”; TSE: 4565) notes that its partner Neurocrine Biosciences Inc. (“Neurocrine”; Nasdaq: NBIX), a leading neuroscience-focused biopharmaceutical company, announced that it has initiated its Phase 1 first-in-human clinical study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of investigational compound NBI-1117567 in healthy adult participants – see Neurocrine press...

FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Name of exempt principal trader: Investec Bank plc (b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Alpha Financial Markets Consulting plc (c) Name of the party to the offer with which exempt...

May 9th, 2024 – NRD Companies, a global IT and consulting group of companies specializing in governance, economic digital infrastructure development, and subject matter consultancy services, has released its 2023 annual report, showcasing remarkable growth and strategic achievements. In 2023, NRD Companies maintained its focus on developing dedicated products and solutions for the E-Government, Banking, and Retail sectors, alongside providing subject matter consultancy services tailored to its...

Tokyo, Japan and Cambridge, UK, 9 May 2024 – Nxera Pharma (“the Company” or “Nxera”; TSE: 4565) provides an update on operational activities and reports its consolidated results for the first quarter ended 31 March 2024. The full report can be found here . Chris Cargill, President and CEO of Nxera, commented: “We entered 2024 with a clear vision to capitalize on a number of strategic opportunities and build on the strong foundations we have created, positioning the business for the...

Travis Perkins (TPK) Travis Perkins: TR1 Notification of Major Share Interest 09-May-2024 / 07:15 GMT/BST TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BK9RKT01 Issuer Name TRAVIS PERKINS PLC UK or Non-UK Issuer UK 2. Reason for Notification An acquisition or disposal of voting rights; An acquisition or disposal of financial instruments 3. Details of person subject to the notification obligation Name Bank of America Corporation City of registered office (if...